The Business Research Company published its Biosimilar Monoclonal Antibodies Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Biosimilar Monoclonal Antibodies market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.
The report covers the Biosimilar Monoclonal Antibodies market’s segments-
1) By Type: Synthetic Chemicals, Biopharmaceuticals, Others
2) By Application: Chronic & Autoimmune Diseases, Oncology, Others
View Complete Report:
https://www.thebusinessresearchcompany.com/report/biosimilar-monoclonal-antibodies-global-market-report-2020-30-covid-19-growth-and-change
Biosimilar Monoclonal Antibodies Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.
The global biosimilar monoclonal antibodies market is expected to decline from $3.21 billion in 2019 to $3.04 billion in 2020 at a compound annual growth rate (CAGR) of -5.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $7.18 billion in 2023 at a CAGR of 33.13%.
The focus areas for many companies in the biosimilar monoclonal antibodies market has shifted to mergers and acquisitions to acquire more production capabilities. Large prime manufactures are forming joint ventures or buying small or midsized companies to acquire new capabilities or to gain access to new markets.
Few Points From Table Of Content
1. Executive Summary
2. Biosimilar Monoclonal Antibodies Market Characteristics
3. Biosimilar Monoclonal Antibodies Market Size And Growth
4. Biosimilar Monoclonal Antibodies Market Segmentation
5. Biosimilar Monoclonal Antibodies Market Regional And Country Analysis
……………
25. Biosimilar Monoclonal Antibodies Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Biosimilar Monoclonal Antibodies Market
27. Biosimilar Monoclonal Antibodies Market Trends And Strategies
28. Biosimilar Monoclonal Antibodies Market Future Outlook and Potential Analysis
29. Appendix
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3412&type=smp
Few Points From List Of Table
Table 1: Global Historic Market Growth, 2015-2019, $ Billion
Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Table 3: Global Biosimilar Monoclonal Antibodies Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
……
Table 45: Pfizer Financial Performance
Table 46: Novartis Financial Performance
Table 47: Allergan Financial Performance
Table 48: Coherus BioSciences Financial Performance
Table 49: Biocon Financial Performance
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information:
The Business Research Company
https://www.thebusinessresearchcompany.com
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
No comments:
Post a Comment